Clinical Trial Update: Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Mecapegfilgrastim with chemotherapy for peripheral blood stem cell mobilization in adults with multiple myeloma or lymphoma is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Mecapegfilgrastim

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Multiple Myeloma, Lymphoma | Phase 2 | Status: RECRUITING